Recent Advances of Platinum‐Based Anticancer Complexes in Combinational Multimodal Therapy
Advanced Healthcare Materials · 2023-09 · 12 (22)
DOI: 10.1002/adhm.202300253 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 14.05.2023. Verfasst von Tianyuan Zhong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chemistry, Northeast Normal University, Changchun, 130024, China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms, Anti-Infective Agents. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 175 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Platinum drugs with manifest therapeutic effects are widely used, but their systemic toxicity and the drug resistance acquired by cancer cells limit their clinical applications. Thus, the exploration on appropriate methods and strategies to overcome the limitations of traditional platinum drugs becomes extremely necessary. Combination therapy of platinum drugs can inhibit tumor growth and metastasis in an additive or synergistic manner, and can potentially reduce the systemic toxicity of platinum drugs and overcome platinum‐resistance. This review summarizes the various modalities and current progress in platinum‐based combination therapy. The synthetic strategies and therapeutic effects of some platinum‐based anticancer complexes in the combination of platinum drugs with gene editing, ROS‐based therapy, thermal therapy, immunotherapy, biological modelling, photoactivation, supramolecular self‐assembly and imaging modality are briefly described. Their potential challenges and prospects are also discussed. It is hoped that this review will inspire researchers to have more ideas for the future development of highly effective platinum‐based anti‐cancer complexes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Chemistry, Northeast Normal University, Changchun, 130024, China.
- Key Laboratory of Sustainable Advanced Functional Materials of Jilin Province, Northeast Normal University, Changchun, 130024, China.
- The Second Affiliated Hospital of Harbin Medical University, Department of Orthopedics, Harbin, 150000, China.
ORCID-Profile: Yubin Huang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhong, T., Yu, J., Pan, Y., Zhang, N., Qi, Y., & Huang, Y. (2023). Recent Advances of Platinum‐Based Anticancer Complexes in Combinational Multimodal Therapy. Advanced Healthcare Materials, 12(22). https://doi.org/10.1002/adhm.202300253
Vancouver
Zhong T, Yu J, Pan Y, Zhang N, Qi Y, Huang Y. Recent Advances of Platinum‐Based Anticancer Complexes in Combinational Multimodal Therapy. Advanced Healthcare Materials. 2023;12(22). doi:10.1002/adhm.202300253
BibTeX
@article{Zhong2023,
author = {Zhong, Tianyuan and Yu, Jie and Pan, Yong and Zhang, Ning and Qi, Yanxin and Huang, Yubin},
title = {Recent Advances of Platinum‐Based Anticancer Complexes in Combinational Multimodal Therapy},
journal = {Advanced Healthcare Materials},
year = {2023},
volume = {12},
number = {22},
doi = {10.1002/adhm.202300253}
}
EUVIMED